Skip to main content
OpenTrials

Clinical trial condition

Diabetic Neuropathies

Explore clinical trials studying Diabetic Neuropathies. Study availability and eligibility vary by location and protocol.

118 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Diabetic Neuropathies trial results

Completed

Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

NCT00228605

Conditions
Arthritis, Back Pain, Brain Diseases, +22 more
Locations
  • MedSearch Calera, Alabama, United States
  • Clinical Research Consultants, Inc. Hoover, Alabama, United States
  • Arizona Research Center Phoenix, Arizona, United States
  • NEA Clinic Jonesboro, Arkansas, United States
View all 38 locations
View Trial Details
Completed

Neuropathic Pain Management

NCT01263132

Conditions
Diabetes Complications, Diabetes Mellitus, Diabetic Neuropathies, +8 more
Locations
  • REMEDI Resultados Médicos Desarrollo e Investigación, S.C. Pachuca, Hidalgo, Mexico
View Trial Details
Completed

Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

NCT00507936

Conditions
Diabetes Complications, Diabetes Mellitus, Diabetic Neuralgia, +13 more
Locations
  • Site Reference ID/Investigator# 5207 Mesa, Arizona, United States
  • Site Reference ID/Investigator# 6053 Phoenix, Arizona, United States
  • Site Reference ID/Investigator# 5206 Little Rock, Arkansas, United States
  • Site Reference ID/Investigator# 7387 North Little Rock, Arkansas, United States
View all 49 locations
View Trial Details
Completed

Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China

NCT00408993

Conditions
Diabetes Complications, Diabetes Mellitus, Diabetic Neuropathies, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjin, China
View Trial Details

Related conditions